Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Embella for reduction of submental fat
IRCT20190210042676N29Phase 2Completed
- Sponsor
- Zist Orchid Pharmed
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sodium deoxycholate in submental fat, sponsored by Zist Orchid Pharmed. Primary endpoint: Grading changes in submental fat. Started Feb 2023; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
submental fat
Beyond the preview
Go deeper on IRCT20190210042676N29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190210042676N29.